Marshall Fordyce, insider filing for VERA
Marshall Fordyce, reporting
VERA
Vera Therapeutics, Inc. SEC filings
Every EDGAR filing for Vera Therapeutics, Inc. (VERA), newest first, with AI summaries and stories.
- Ticker
- VERA
- CIK
- 1831828
- Latest filing
- Sep 17
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4Vera Therapeutics, Inc.VERALIVE ROUTINE8-KVera Therapeutics, Inc.VERALIVE ROUTINE4Vera Therapeutics, Inc.VERALIVE Joseph R Young, insider filing for VERA
Joseph R Young, reporting
ROUTINE4Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, insider filing for VERA
Marshall Fordyce, reporting
ROUTINE144Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, planned sale of VERA shares
Marshall Fordyce, reporting
ROUTINE4/AVera Therapeutics, Inc.VERALIVE 3 insider filings
Marshall Fordyce, insider filing for VERA (amended)
Show all 3
- 4/AInsider filing for VERA (amended)
- 4/AInsider filing for VERA (amended)
- 4/AInsider filing for VERA (amended)
Marshall Fordyce, reporting
ROUTINESCHEDULE 13G/AVera Therapeutics, Inc.VERALIVE Ownership stake disclosure by Kynam Capital Management, LP (amended)
Kynam Capital Management, LP, filed by
NOTABLE10-QVera Therapeutics, Inc.VERALIVE ROUTINE8-KVera Therapeutics, Inc.VERALIVE ROUTINESCHEDULE 13GVera Therapeutics, Inc.VERALIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
ROUTINE4Vera Therapeutics, Inc.VERALIVE 2 insider filings
Nancy Lee Boman, insider filing for VERA
Show all 2
- 4Insider filing for VERA
- 3New insider at VERA
Nancy Lee Boman, reporting
ROUTINESCHEDULE 13G/AVera Therapeutics, Inc.VERALIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE4Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, insider filing for VERA
Marshall Fordyce, reporting
ROUTINE8-KVera Therapeutics, Inc.VERALIVE ROUTINE8-KVera Therapeutics, Inc.VERALIVE ROUTINE4Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, insider filing for VERA
Marshall Fordyce, reporting
ROUTINE144Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, planned sale of VERA shares
Marshall Fordyce, reporting
ROUTINE8-KVera Therapeutics, Inc.VERALIVE ROUTINE8-KVera Therapeutics, Inc.VERALIVE ROUTINE4Vera Therapeutics, Inc.VERALIVE 8 insider filings
Scott W Morrison, insider filing for VERA
Show all 8
- 4Insider filing for VERA
- 4Insider filing for VERA
- 4Insider filing for VERA
- 4Insider filing for VERA
- 4Insider filing for VERA
- 4Insider filing for VERA
- 4Insider filing for VERA
- 4Insider filing for VERA
Scott W Morrison, reporting
ROUTINESCHEDULE 13G/AVera Therapeutics, Inc.VERALIVE Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/ (amended)
PRICE T ROWE ASSOCIATES INC /MD/, filed by
ROUTINE4Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, insider filing for VERA
Marshall Fordyce, reporting
ROUTINE144Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, planned sale of VERA shares
Marshall Fordyce, reporting
NOTABLE10-QVera Therapeutics, Inc.VERALIVE ROUTINE8-KVera Therapeutics, Inc.VERALIVE ROUTINE4Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, insider filing for VERA
Marshall Fordyce, reporting
ROUTINE144Vera Therapeutics, Inc.VERALIVE Marshall Fordyce, planned sale of VERA shares
Marshall Fordyce, reporting
ROUTINEARSVera Therapeutics, Inc.VERALIVE ROUTINEDEF 14AVera Therapeutics, Inc.VERALIVE ROUTINEDEFA14AVera Therapeutics, Inc.VERALIVE ROUTINESCHEDULE 13GVera Therapeutics, Inc.VERALIVE Ownership stake disclosure by Point72 Asset Management, L.P.
Point72 Asset Management, L.P., filed by
ROUTINESCHEDULE 13G/AVera Therapeutics, Inc.VERALIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINE4Vera Therapeutics, Inc.VERALIVE 2 insider filings
Jane Wright-Mitchell, insider filing for VERA
Show all 2
- 4Insider filing for VERA
- 3New insider at VERA
Jane Wright-Mitchell, reporting
ROUTINE4Vera Therapeutics, Inc.VERALIVE Joseph R Young, insider filing for VERA
Joseph R Young, reporting
ROUTINESCHEDULE 13GVera Therapeutics, Inc.VERALIVE Ownership stake disclosure by Deep Track Capital, LP
Deep Track Capital, LP, filed by
ROUTINE8-KVera Therapeutics, Inc.VERALIVE ROUTINE4Vera Therapeutics, Inc.VERALIVE 2 insider filings
Christopher Hite, insider filing for VERA
Show all 2
- 4Insider filing for VERA
- 3New insider at VERA
Christopher Hite, reporting
NOTABLESCHEDULE 13D/AVera Therapeutics, Inc.VERALIVE Ownership stake disclosure by Sofinnova Venture Partners X, L.P. (amended)
Sofinnova Venture Partners X, L.P., filed by